(Q31055424)

28 June 2017

Evaluation of SIV library vaccines with genetic cytokines in a macaque challenge (English)

1 reference

28 June 2017

0 references

Kathryn F Sykes

1

1 reference

28 June 2017

Mark G Lewis

series ordinal

2

1 reference

28 June 2017

Burke Squires

series ordinal

3

1 reference

28 June 2017

Stephen Albert Johnston

series ordinal

4

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

28 June 2017

1 reference

28 June 2017

20

1 reference

28 June 2017

17-18

1 reference

28 June 2017

2382-2395

1 reference

AIDS now world's fourth biggest killer

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Current progress in the development of human immunodeficiency virus vaccines: research and clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

The moving target: mechanisms of HIV persistence during primary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Is an HIV vaccine possible?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Towards an HIV-1 vaccine: lessons from studies in macaque models

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Simian immunodeficiency virus DNA vaccine trial in macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Progress in the development of an HIV-1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Challenges and opportunities for development of an AIDS vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Attenuated HIV vaccine: caveats.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Protection against mycoplasma infection using expression-library immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Expression library immunization to identify protective antigens from Cowdria ruminantium

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Protection against murine cysticercosis using cDNA expression library immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Specific cellular and humoral immune response in Balb/c mice immunised with an expression genomic library of Trypanosoma cruzi.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Expression library immunization protects mice against a challenge with virulent rodent malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Genetic live vaccines mimic the antigenicity but not pathogenicity of live viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Titration and characterization of two rhesus-derived SIVmac challenge stocks

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

An African primate lentivirus (SIVsm) closely related to HIV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Assessment of gag DNA and genomic RNA in peripheral blood mononuclear cells in HIV-infected patients receiving intervention with a recombinant gp 160 subunit vaccine in a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: predictive value for disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

The role of nonhuman primate models in AIDS vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Biological features of genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900094-4

7 January 2021

10.1016/S0264-410X(02)00094-4

Identifiers

DOI

1 reference

28 June 2017

1 reference